FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2818-2820 December 29, 2005 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Nigro, G. PubMed Citation

To the Editor: Nigro et al. (Sept. 29 issue)¹ report on the administration of cytomegalovirus (CMV) hyperimmune globulin to 68 pregnant women with primary CMV infection and conclude that this treatment "may be effective in the treatment and prevention of congenital CMV infection." However, 39 of 45 newborns with amniocentesis-proven congenital infection still shed virus at birth, and in utero infection was never documented in the remaining 84 newborns in the "prevention" group (in which women who had a recent primary infection before 21 weeks' gestation or who declined amniocentesiswere offered monthly hyperimmune globulin), only 37 of whose mothers received . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.